Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
暂无分享,去创建一个
L. Fisher | J. Cohn | A. Maggioni | G. Tognoni | R. Latini | S. Masson | I. Anand | R. Glazer | Y. Chiang
[1] Nader Rifai,et al. Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide , 2002, Circulation.
[2] I. Anand,et al. Neurohormonal Responses in Congestive Heart Failure: Effect of Ace Inhibitors in Randomized Controlled Clinical Trials , 1995 .
[3] J. Cohn,et al. Effects of Valsartan on Circulating Brain Natriuretic Peptide and Norepinephrine in Symptomatic Chronic Heart Failure: The Valsartan Heart Failure Trial (Val-HeFT) , 2002, Circulation.
[4] L. Fisher,et al. Surrogate end points in heart failure. , 2002, Journal of the American College of Cardiology.
[5] J. Cohn,et al. Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. , 2000, Journal of the American College of Cardiology.
[6] A. Skene,et al. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure , 1997, The Lancet.
[7] J. Cohn,et al. Plasma Norepinephrine, Plasma Renin Activity, and Congestive Heart Failure Relations to Survival and the Effects of Therapy in V‐HeFT II , 1993, Circulation.
[8] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[9] N. Hollenberg,et al. Literature alert , 2002 .
[10] J. S. Janicki,et al. Cardiac myocyte necrosis induced by angiotensin II. , 1991, Circulation research.
[11] B. Massie,et al. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. , 1985, The American journal of cardiology.
[12] C. Frampton,et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. , 1998, Circulation.
[13] L. Tavazzi,et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. , 2001, Journal of the American College of Cardiology.
[14] D. Murdoch,et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. , 1999, American heart journal.
[15] B. Massie,et al. Survival of patients with congestive heart failure: past, present, and future prospects. , 1987, Circulation.
[16] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[17] B. Greenberg,et al. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators. , 1995, The American journal of cardiology.
[18] N. Dhalla,et al. Heart Hypertrophy and Failure , 1995, Developments in Cardiovascular Medicine.
[19] S. Yusuf,et al. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction , 1995 .
[20] B. Parsons,et al. Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte , 1992, Circulation.
[21] L. Horowitz,et al. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. , 1983, Journal of the American College of Cardiology.
[22] K. Swedberg,et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.
[23] C. Frampton,et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations , 2000, The Lancet.
[24] R. Latini,et al. Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts. , 2002, Journal of cardiac failure.